MAP2K1 and infection: On day 1 after infection, CFU in lung homogenates were no longer significantly different between groups (Fig. 4E); however, overall bacterial clearance on day 1 after infection is high in this model of infection, demonstrating robust clearance that is not impaired by either MEK1/2 inhibitor treatment.